What is the main purpose of the study discussed in the research?
Click to see answer
What is the main purpose of the study discussed in the research?
To correlate radiation dose distributions with areas of myocardial fibrosis using cardiac MRI techniques.
What cardiac MRI techniques were utilized in the study?
Late gadolinium enhancement (LGE) and T1 mapping.
What is a well-established complication of radiotherapy for mediastinal lymphomas and other cancers?
Cardiac toxicity.
What was the location of the maximum heart dose in the study?
Outside the contoured LGE volume in all 9 patients.
How many patients participated in the study?
Twenty-eight patients.
What is the assumed time frame for the development of cardiac fibrosis after radiotherapy?
Within 6 months after radiotherapy.
What late effects can result from incidental radiotherapy to the heart?
Pericarditis, myocarditis, and coronary artery disease.
Was there a geographic relationship between the dose to coronary vessels and myocardial areas of enhancement?
No, there was no geographic relationship.
What types of tumors did the patients have?
Lung, breast, esophagus, and lymphoma tumors.
What type of images were obtained starting at 10 minutes post-contrast?
Resolution gradient echo inversion recovery LGE images.
What was the median time from the end of treatment to CMR acquisition in the study?
24.6 months.
How can delivering radiation dose to the heart affect patient outcomes?
It can increase the risk for late competing toxicity, leading to non-cancer morbidity and mortality.
What was the p-value indicating the association between EQD2 Dmax and Dmean in the LGE area and the size of the LGE volume?
p = 0.13 and p = 0.78, respectively.
What was the average time after radiotherapy that patients underwent CMR?
46.4 months.
What were the specific variables calculated in the study related to LGE volumes?
LGE volume, mean and maximum dose to enhancing volume (LGE Dmean and LGE Dmax), mean and maximum dose to the heart (heart Dmean and heart Dmax), mean and maximum dose to the left ventricle (LV Dmean and LV Dmax), minimum dose to 95% of the LGE volume (D95), and volume of heart and left ventricle receiving defined radiation doses (V5/30/40/50Gy).
What software was used for post-processing of the images?
Dedicated Precession imaging analysis software.
What was the median interval between radiotherapy and CMR for patients demonstrating enhancement?
11.9 months.
What imaging modalities are used to evaluate radiation-induced heart disease (RIHD)?
Echocardiography, stress echocardiography, SPECT perfusion, cardiac CT, and cardiac MRI.
What trend was observed in patients with evidence of LGE?
A trend towards higher T1 values (p = 0.054).
What was the average maximum dose (Dmax) delivered to the heart in the study?
50.9 Gy.
What was the average Dmax EQD2 dose to the heart for the entire cohort?
50.9 Gy (range 6.2 – 108.0).
Which cardiac structures were contoured on CT for consistency?
Right and left ventricles, right and left atria, pericardium, and cardiac vasculature.
What limitation was noted regarding the study's assessment of myocardial damage?
No pre-radiotherapy CMRs were acquired.
What advantage does cardiac MRI (CMR) offer in evaluating RIHD?
It provides precise visualization of anatomical structures and quantification of cardiac function in a noninvasive manner.
What was the average T1 value of the left myocardium and septum in the study?
1009 ms (range 933 – 1117 ms).
What was the average T1 value of the left ventricle myocardium observed?
1009 ms.
What was the average survival time for patients with LGE?
11.9 months.
What statistical methods were used in the study?
Univariate comparisons (t-tests and Fisher exact tests), two-sided t-test for T1 mapping values, and linear regression using ordinary least squares method.
What was the purpose of the rigid registration process?
To fuse CMR to the CT simulation scans.
What was the main finding regarding the association between radiation dose and myocardial changes in the study?
No association was identified between radiation dose and myocardial changes using the techniques studied.
What was the primary focus of the CMR assessment in this study?
Myocardial damage and cardiomyopathy.
What is Late Gadolinium Enhancement (LGE) used for in cardiac imaging?
To determine ischemic and non-ischemic focal fibrosis of the myocardium.
What was the correlation between heart Dmax and Dmean and T1 mapping values?
No significant correlation was seen (heart p = 0.139 and 0.575).
What significant correlation was found between cardiac doses and T1 values?
No significant correlation was observed.
What was the average survival time for patients without LGE?
31.4 months.
How many patients demonstrated areas of late gadolinium enhancement (LGE)?
Nine patients.
Who performed the delineation of LGE volumes?
One radiation oncologist in conjunction with board-certified radiologists.
What predictive factors for RIHD were included in the analysis?
Whole heart and left ventricle V5Gy, V30Gy, V40Gy, and V50Gy.
What was the conclusion regarding the relationship between cardiac radiation dose and localized fibrosis?
No relationship was seen using LGE on CMR.
What does T1 mapping in CMR help detect?
Diffuse myocardial fibrosis.
What is the goal of identifying patients at risk of RIHD after radiotherapy?
To institute preventive measures and early interventions.
What conclusion was drawn regarding the relationship between cardiac doses and the presence of LGE?
No relation was observed.
What was the mean volume of LGE in patients who developed it?
2.3 ml.
What was the mean time from end of radiation treatment to CMR acquisition?
46.4 months (range 1.7 – 344.5).
How were T1 values calculated in this study?
Using average T1 values from the mid-ventricle short axis slice.
What was observed about the location of cardiac Dmax in relation to LGE volume?
Cardiac Dmax was located outside the LGE volume in all patients with demonstrated LGE.
What is suggested for future studies to better understand myocardial changes post-radiotherapy?
Longitudinal assessment and volumetric CMR imaging.
What is the relationship between T1 relaxation times and myocardial fibrosis?
Longer T1 relaxation times represent more interstitial fibrosis.
What was the purpose of the pilot study mentioned in the discussion?
To determine the usefulness of CMRs in the detection of preclinical RIHD.
What were the average cardiac EQD2 Dmax and Dmean in patients with LGE?
Dmax: 60.8 Gy, Dmean: 6.8 Gy.
What percentage of patients received chemotherapy?
75%.
What was explored through dosimetric analysis?
The dose response relationship between cardiac dose and both left ventricular T1 values and areas of LGE.
What trend was observed in T1 values in patients with evidence of LGE?
There was a trend towards higher T1 values in patients with evidence of LGE, indicating local fibrosis changes.
What was a notable finding regarding patients with LGE in terms of radiation dose?
Patients with LGE had lower maximum and mean doses compared to no-LGE patients.
What was the hypothesis of the study regarding high dose regions of radiotherapy?
That they correlate to areas of LGE and T1 mapping on CMR.
What were the average EQD2 Dmax and Dmean to the left ventricle in patients with LGE?
Dmax: 43.8 Gy, Dmean: 7.6 Gy.
What was the average Dmean EQD2 dose to the left ventricle?
8.2 Gy (range 0.1 – 34.4).
What was visualized on the axial CT plane for dosimetric analysis?
Isodose distributions and areas of LGE.
What did the study by Huang et al. find regarding fibrosis volume on CMR?
They found a linear relationship between EQD2 Dmean and Dmax doses delivered to the left and right atrium and the fibrosis volume on CMR.
What anatomical changes were accounted for in the study's image fusion process?
Rotations, translations, and changes in magnitude aligned to the left ventricle.
What criteria were used for patient selection in the study?
Patients who had undergone thoracic radiotherapy with at least 10% of the heart receiving 5 Gy or more.
What were the average EQD2 Dmax and Dmean for patients without LGE?
Dmax: 46.1 Gy, Dmean: 8.8 Gy.
What was the alpha/beta ratio used for heart dose conversion?
2 Gy.
What was done if patients received more than one radiotherapy course?
Composite radiotherapy plans were created.
What was a significant finding in the study by Umezawa et al. regarding LGE?
Fifty percent of patients demonstrated LGE localized within segments of 40Gy and 60Gy isodose distributions.
Was there a significant difference in EQD2 Dmax or Dmean between patients with and without LGE?
No significant difference was seen (p = 0.16 and 0.57, respectively).
What types of cancer were most prevalent in the patient cohort?
Lung and breast cancer.
What was the significance of the T1 value detected in the case study of a 70-year-old male?
The T1 time of 1303 ms was at the upper limit of the reference range, indicating potential interstitial fibrosis and myocardial degeneration.
What was the EQD2 Dmax and Dmean to the LGE volume itself?
Dmax: 16.4 Gy, Dmean: 7.5 Gy.
What did Tuohenin et al. find regarding T1 relaxation times in patients after radiotherapy?
Diffuse T1 relaxation times averaged 1210 ms in inferoseptal segments, with 35% of values greater than 1250 ms, significantly higher than in other regions.
What does D95 represent in the context of LGE volumes?
Minimum dose to 95% of the LGE volume.
What was the mean T1 value at baseline prior to radiotherapy in the study by Takagi et al.?
The mean T1 value was 1183 ms (+/− 46).
What was the average age of patients demonstrating LGE?
66 years (range: 50 – 87).
